Aethlon Medical AEMD Insider Ownership

NASDAQ AEMD
$5.07 -0.24 (-4.52%)
At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

101.25K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
3.59%
▼-0.186% pp QoQ
Shares Held by Insiders
17.13K
filed for Sep 2026
▼-4.94% QoQ
Shares Outstanding
477.40K
477,402 shares
Direct Holdings
17.13K
Indirect: 0
Net Shares Traded (QoQ)
-890
net selling in Sep 2026
Insiders Holding Shares
7
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Updated

Over the trailing 12 months, AEMD insiders made no open-market trades in the stock.

Form 4 Holdings

Insiders Holding AEMD

Insiders 7
Shares held 101.25K
Of outstanding 21.21%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 James B Frakes Cfo/Ceo 42,063 0 42,063 41.5% 13 Oct, 2026
2 Steven P Larosa Chief Medical Officer 42,057 0 42,057 41.5% 15 Oct, 2026
3 Angela Rossetti Director 5,241 0 5,241 5.2% 21 Apr, 2026
4 Edward G Broenniman Director 4,313 0 4,313 4.3% 15 Oct, 2026
5 Chetan Shah Director 3,787 0 3,787 3.7% 15 Oct, 2026
6 Nicolas Gikakis Director 3,784 0 3,784 3.7% 15 Oct, 2026
7 Sabrina Martucci Johnson Director 8 0 8 0.0% 31 Mar, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

317 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
30 Sep, 2026 Nicolas Gikakis Director Disposed F 436 $6.52 $2.84K 3,784 Direct
30 Sep, 2026 Chetan Shah Director Disposed F 436 $6.52 $2.84K 3,787 Direct
08 Oct, 2026 Steven P Larosa Chief Medical Officer Acquired A 42,000 $0.00 $0 42,057 Direct
30 Sep, 2026 Edward G Broenniman Director Disposed F 218 $6.52 $1.42K 4,313 Direct
08 Oct, 2026 James B Frakes Cfo/Ceo Acquired A 42,000 $0.00 $0 42,063 Direct
30 Jun, 2026 Edward G Broenniman Director Disposed F 1,091 $4.10 $4.47K 4,473 Direct
30 Jun, 2026 Nicolas Gikakis Director Disposed F 2,182 $4.10 $8.95K 4,133 Direct
30 Jun, 2026 Chetan Shah Director Disposed F 2,182 $4.10 $8.95K 4,168 Direct
17 Apr, 2026 Nicolas Gikakis Director Acquired A 21,815 $11.45 $249.78K 4,569 Direct
17 Apr, 2026 Angela Rossetti Director Acquired A 21,815 $11.45 $249.78K 5,241 Direct
17 Apr, 2026 Chetan Shah Director Acquired A 21,815 $11.45 $249.78K 4,604 Direct
17 Apr, 2026 Edward G Broenniman Director Acquired A 21,815 $11.45 $249.78K 4,691 Direct
31 Mar, 2026 Nicolas Gikakis Director Disposed F 178 $10.95 $1.95K 293 Direct
31 Mar, 2026 Edward G Broenniman Director Disposed F 89 $10.95 $975 383 Direct
31 Mar, 2026 Chetan Shah Director Disposed F 178 $10.95 $1.95K 293 Direct
31 Dec, 2025 Edward G Broenniman Director Disposed F 89 $13.85 $1.23K 561 Direct
31 Dec, 2025 Chetan Shah Director Disposed F 179 $13.85 $2.48K 471 Direct
31 Dec, 2025 Nicolas Gikakis Director Disposed F 179 $13.85 $2.48K 471 Direct
30 Sep, 2025 Nicolas Gikakis Director Disposed F 1,786 $37.45 $66.89K 454 Direct
30 Sep, 2025 Chetan Shah Director Disposed F 1,786 $37.45 $66.89K 453 Direct